Weight Loss Improves β-Cell Function in People With Severe Obesity and Impaired Fasting Glucose: A Window of Opportunity
Author(s) -
Amy E. Rothberg,
William H. Herman,
Chun-Yi Wu,
Heidi B. IglayReger,
Jeffrey F. Horowitz,
Charles Burant,
Andrzej T. Gałecki,
Jeffrey B. Halter
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgz189
Subject(s) - impaired fasting glucose , weight loss , medicine , type 2 diabetes , obesity , insulin resistance , body mass index , endocrinology , diabetes mellitus , insulin , impaired glucose tolerance
In people with obesity, β-cell function may adapt to insulin resistance. We describe β-cell function in people with severe obesity and normal fasting glucose (NFG), impaired fasting glucose (IFG), and type 2 diabetes (T2DM), as assessed before, 3 to 6 months after, and 2 years after medical weight loss to describe its effects on insulin sensitivity, insulin secretion, and β-cell function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom